REVIEW ARTICLE: Antimicrobial Polypeptides are Key Anti‐HIV‐1 Effector Molecules of Cervicovaginal Host Defense

Mucosal surfaces of the cervix and vagina are portals for heterosexual transmission of human immunodeficiency virus type 1 (HIV‐1) and, therefore, play a fundamental role in the pathogenesis of primary infection. Cationic antimicrobial polypeptides including defensins are the principal effector molecules of mucosal innate immunity against microbes and viruses such as HIV. In cervicovaginal secretions, antimicrobial polypeptides constitute the majority of the intrinsic anti‐HIV‐1 activity, synergism between cationic polypeptides is complex, and full anti‐HIV‐1 activity involves the complete complement of cationic polypeptides. Periods in which cationic antimicrobial polypeptide expression is reduced are likely associated with increased susceptibility to HIV‐1 infection. This review provides an overview of the role of cationic antimicrobial polypeptides in innate cervicovaginal anti‐HIV‐1 host defense, and discusses how hormones and bacterial infections can regulate their expression. Emphasis is placed on the θ‐defensin (retrocyclin) class of anti‐HIV‐1 peptides and their potential for development as topical microbicides to prevent HIV‐1 transmission.

[1]  R I Lehrer,et al.  Defensins: antimicrobial and cytotoxic peptides of mammalian cells. , 1993, Annual review of immunology.

[2]  C. Roumestand,et al.  Change in membrane permeability induced by protegrin 1: implication of disulphide bridges for pore formation , 1996, FEBS letters.

[3]  P. McCray,et al.  Human airway epithelia express a beta-defensin. , 1997, American journal of respiratory cell and molecular biology.

[4]  L. M. Mansky,et al.  Forward mutation rate of human immunodeficiency virus type 1 in a T lymphoid cell line. , 1996, AIDS research and human retroviruses.

[5]  T. Ganz,et al.  Human defensin gene copy number polymorphisms: Comprehensive analysis of independent variation in α- and β-defensin regions at 8p22–p23 , 2005 .

[6]  Christina H. Park,et al.  Antimicrobial components of vaginal fluid. , 2002, American journal of obstetrics and gynecology.

[7]  Defensins. Natural peptide antibiotics of human neutrophils. , 1985 .

[8]  M. Lederman,et al.  Human epithelial beta-defensins 2 and 3 inhibit HIV-1 replication. , 2003, AIDS.

[9]  R. Lehrer,et al.  Gallinacin-3, an Inducible Epithelial β-Defensin in the Chicken , 2001, Infection and Immunity.

[10]  A. Cole,et al.  Cationic Polypeptides Are Required for Anti-HIV-1 Activity of Human Vaginal Fluid1 , 2005, The Journal of Immunology.

[11]  T. Ganz.  Defensins: antimicrobial peptides of innate immunity , 2003, Nature Reviews Immunology.

[12]  V. Maiorov,et al.  Structural and functional modeling of human lysozyme reveals a unique nonapeptide, HL9, with anti-HIV activity. , 2005, Biochemistry.

[13]  L. M. Mansky,et al.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase , 1995, Journal of virology.

[14]  Á. Zaballos,et al.  NMR Solution Structure of Murine CCL20/MIP-3α, a Chemokine That Specifically Chemoattracts Immature Dendritic Cells and Lymphocytes through Its Highly Specific Interaction with the β-Chemokine Receptor CCR6* , 2001, The Journal of Biological Chemistry.

[15]  T. Ganz,et al.  DEFENSINS: NATURAL PEPTIDE ANTIBIOTICS IN HUMAN NEUTROPHILS , 1986 .

[16]  H. Critchley,et al.  Innate immune defences in the human endometrium , 2003, Reproductive biology and endocrinology : RB&E.

[17]  J. Levy,et al.  α-Defensins can have anti-HIV activity but are not CD8 cell anti-HIV factors , 2003, AIDS.

[18]  B. Schonwetter,et al.  Epithelial antibiotics induced at sites of inflammation. , 1995, Science.

[19]  D. Craik,et al.  Three-dimensional structure of RTD-1, a cyclic antimicrobial defensin from Rhesus macaque leukocytes. , 2001, Biochemistry.

[20]  D. Clanton,et al.  Human immunodeficiency virus type-1 (HIV-1) replication is unaffected by human secretory leukocyte protease inhibitor. , 1996, Antiviral research.

[21]  R. Gray,et al.  HIV infection and disturbances of vaginal flora during pregnancy. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[22]  N. Fujii,et al.  Defensins inhibit HIV replication in vitro. , 1993, AIDS.

[23]  S. Kennedy,et al.  Candida infection as a risk factor for HIV transmission. , 2003, Journal of women's health.

[24]  D. Hoover,et al.  The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. , 2002, The Journal of biological chemistry.

[25]  E. Greenberg,et al.  Production of β-defensins by human airway epithelia , 1998 .

[26]  L. Meyn,et al.  Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[27]  N. Fujii,et al.  An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. , 1996, Biochemistry.

[28]  A. Waring,et al.  Two states of cyclic antimicrobial peptide RTD-1 in lipid bilayers. , 2002, Biochemistry.

[29]  T. Kanzaki,et al.  Secretory leukocyte protease inhibitor levels in cervicovaginal secretion of elderly women. , 2006, Maturitas.

[30]  E. Greenberg,et al.  Production of beta-defensins by human airway epithelia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[31]  E. Valore,et al.  Reversible Deficiency of Antimicrobial Polypeptides in Bacterial Vaginosis , 2006, Infection and Immunity.

[32]  J. Andersson,et al.  Repertoire of chemokine receptor expression in the female genital tract: implications for human immunodeficiency virus transmission. , 1998, The American journal of pathology.

[33]  D. Ho,et al.  In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5 , 2001, Journal of Virology.

[34]  J. Sallenave,et al.  Differential regulation of secretory leukocyte protease inhibitor and elafin by progesterone. , 2003, Biochemical and biophysical research communications.

[35]  T. Ganz,et al.  Neutrophil defensins: purification, characterization, and antimicrobial testing. , 1994, Methods in enzymology.

[36]  R. Lehrer,et al.  Evolution of primate theta-defensins: a serpentine path to a sweet tooth. , 2003, Peptides.

[37]  M. ColeA,et al.  レトロサイクリン HIV‐1のT‐及びM‐親和性株による感染から細胞を保護する霊長類ペプチド , 2002 .

[38]  A. Pardi,et al.  Solution structure of bovine neutrophil beta-defensin-12: the peptide fold of the beta-defensins is identical to that of the classical defensins. , 1995, Biochemistry.

[39]  E. De Clercq,et al.  Antiviral effects of plasma and milk proteins: lactoferrin shows potent activity against both human immunodeficiency virus and human cytomegalovirus replication in vitro. , 1995, The Journal of infectious diseases.

[40]  Michelle de Souza,et al.  Bacterial vaginosis and susceptibility to HIV infection in South African women: a nested case-control study. , 2005, The Journal of infectious diseases.

[41]  W. Okulicz,et al.  Microarray profiling of progesterone-regulated endometrial genes during the rhesus monkey secretory phase , 2004, Reproductive biology and endocrinology : RB&E.

[42]  G. Steffens,et al.  Antibacterial activity of antileukoprotease , 1996, Infection and immunity.

[43]  A. Cole,et al.  Innate host defense of human vaginal and cervical mucosae. , 2007, Current topics in microbiology and immunology.

[44]  S. Wahl,et al.  Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. , 1997, Blood.

[45]  P. Guyre,et al.  Lipopolysaccharide-Induced IL-1β Production by Human Uterine Macrophages Up-Regulates Uterine Epithelial Cell Expression of Human β-Defensin 21 , 2006, The Journal of Immunology.

[46]  Theresa L. Chang,et al.  Dual role of a-defensin-1 in antiHIV-1 innate immunity , 2005 .

[47]  A. Waring,et al.  RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. , 2004, AIDS research and human retroviruses.

[48]  R. Lehrer,et al.  Evolution of primate θ-defensins: a serpentine path to a sweet tooth , 2003, Peptides.

[49]  T. Ganz,et al.  Copy number polymorphisms are not a common feature of innate immune genes. , 2006, Genomics.

[50]  R. Kelly,et al.  Presence of secretory leukocyte protease inhibitor in human endometrium and first trimester decidua suggests an antibacterial protective role. , 2000, Molecular human reproduction.

[51]  D. Ho,et al.  In Vivo Distribution of the Human Immunodeficiency Virus/Simian Immunodeficiency Virus Coreceptors: CXCR4, CCR3, and CCR5 , 1998, Journal of Virology.

[52]  A. Haase,et al.  Transmission, acute HIV-1 infection and the quest for strategies to prevent infection , 2003, Nature Medicine.

[53]  M. Lederman,et al.  Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication , 2003 .

[54]  J. Schröder.  Epithelial antimicrobial peptides: innate local host response elements , 1999, Cellular and Molecular Life Sciences CMLS.

[55]  D. Hoover,et al.  The Structure of Human Macrophage Inflammatory Protein-3α/CCL20 , 2002, The Journal of Biological Chemistry.

[56]  T. Ganz,et al.  Human defensin gene copy number polymorphisms: comprehensive analysis of independent variation in alpha- and beta-defensin regions at 8p22-p23. , 2005, Genomics.

[57]  G. Preti,et al.  Vaginal odors and secretions. , 1981, Clinical obstetrics and gynecology.

[58]  D. Dripps,et al.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. , 1995, The Journal of clinical investigation.

[59]  R. Bals,et al.  The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[60]  O. Yang,et al.  HIV-1 Adapts to a Retrocyclin with Cationic Amino Acid Substitutions That Reduce Fusion Efficiency of gp411 , 2006, The Journal of Immunology.

[61]  R. Steinman,et al.  Myeloid dendritic cells , 1999, Journal of leukocyte biology.

[62]  K. Agnew,et al.  The Effect of Treatment Regimens for Vaginitis and Cervicitis on Vaginal Colonization by Lactobacilli , 1995, Sexually transmitted diseases.

[63]  S. Freel,et al.  Endogenous salivary inhibitors of human immunodeficiency virus. , 1999, Archives of oral biology.

[64]  Y. Shai,et al.  Structure and orientation of the mammalian antibacterial peptide cecropin P1 within phospholipid membranes. , 1996, Journal of molecular biology.

[65]  R I Lehrer,et al.  Antimicrobial peptides of vertebrates. , 1998, Current opinion in immunology.

[66]  S. Lee-Huang,et al.  Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[67]  C. Zhao,et al.  Gallinacin-3, an inducible epithelial beta-defensin in the chicken. , 2001, Infection and immunity.

[68]  G. Spear,et al.  Bacterial vaginosis and host immunity , 2007, Current HIV/AIDS reports.

[69]  Theresa L. Chang,et al.  Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity. , 2005, The Journal of clinical investigation.

[70]  Phalguni Gupta,et al.  The retrocyclin analogue RC‐101 prevents human immunodeficiency virus type 1 infection of a model human cervicovaginal tissue construct , 2007, Immunology.

[71]  O. Yang,et al.  Retrocyclin: A primate peptide that protects cells from infection by T- and M-tropic strains of HIV-1 , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[72]  Fang-Yu Chen,et al.  Evidence for membrane thinning effect as the mechanism for peptide-induced pore formation. , 2003, Biophysical journal.

[73]  E. Clark,et al.  Role of dendritic and follicular dendritic cells in HIV infection and pathogenesis. , 1997, Current opinion in immunology.

[74]  A. Waring,et al.  Circular minidefensins and posttranslational generation of molecular diversity , 2001, Journal of leukocyte biology.

[75]  M. Krohn,et al.  Bacterial vaginosis is a strong predictor of Neisseria gonorrhoeae and Chlamydia trachomatis infection. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[76]  M. Krohn,et al.  Levels of vaginal secretory leukocyte protease inhibitor are decreased in women with lower reproductive tract infections. , 2000, American journal of obstetrics and gynecology.

[77]  M. Selsted,et al.  Homodimeric theta-defensins from rhesus macaque leukocytes: isolation, synthesis, antimicrobial activities, and bacterial binding properties of the cyclic peptides. , 2002, The Journal of biological chemistry.

[78]  T. Ganz,et al.  Innate Antimicrobial Activity of Nasal Secretions , 1999, Infection and Immunity.

[79]  S. Mok,et al.  Gene expression, immunolocalization, and secretion of human defensin-5 in human female reproductive tract. , 1998, The American journal of pathology.

[80]  Christopher J. Miller,et al.  Isolation, Characterization, cDNA Cloning, and Antimicrobial Properties of Two Distinct Subfamilies of α-Defensins from Rhesus Macaque Leukocytes , 1999, Infection and Immunity.

[81]  N. Sewankambo,et al.  HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis , 1997, The Lancet.

[82]  P. D. Smith,et al.  Mucosal events in the pathogenesis of human immunodeficiency virus type 1 infection. , 1999, The Journal of infectious diseases.

[83]  A. Fleming.  On a Remarkable Bacteriolytic Element Found in Tissues and Secretions , 1922 .

[84]  T. Ganz.  Defensins and Host Defense , 1999, Science.

[85]  D R Hoover,et al.  Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV , 1998, AIDS.

[86]  R. Grenman,et al.  Group II phospholipase A2 in nasal fluid, mucosa and paranasal sinuses. , 1997, Acta oto-laryngologica.

[87]  C. Wira,et al.  Effects of Estradiol on Lipopolysaccharide and Pam3Cys Stimulation of CCL20/Macrophage Inflammatory Protein 3 Alpha and Tumor Necrosis Factor Alpha Production by Uterine Epithelial Cells in Culture , 2005, Infection and Immunity.

[88]  S J Ludtke,et al.  Membrane pores induced by magainin. , 1996, Biochemistry.

[89]  D. Savitz,et al.  Bacterial vaginosis associated with HIV infection in pregnant women from North Carolina. , 1999, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[90]  K. Shimoya,et al.  Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. , 1999, Molecular human reproduction.